Non-risk-adapted surveillance in clinical stage i nonseminomatous germ cell tumors: The Princess Margaret Hospital's experience

European Urology

Volumn 59, Issue 4, 2011, Pages 556-562

  Sturgeon, Jeremy F ^a   Moore, Malcolm J ^a   Kakiashvili, David M ^a   Duran, Ignacio ^a   Anson Cartwright, Lynn C ^a   Berthold, Dominik R ^a   Warde, Padraig R ^a   Gospodarowicz, Mary K ^a   Alison, Ruth E ^a   Liu, Justin ^a   Ma, Clement ^a   Pond, Greg R ^a   Jewett, Michael A ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Non risk adapted; Nonseminomatous germ cell tumors; Stage I surveillance

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; DACTINOMYCIN; ETOPOSIDE; VINBLASTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; DISEASE SURVEILLANCE; EMBRYONAL CARCINOMA; HIGH RISK PATIENT; HUMAN; LUNG CANCER; LUNG RESECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; TESTIS CANCER;

ADULT; COHORT STUDIES; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; ONTARIO; ORCHIECTOMY; POPULATION SURVEILLANCE; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 79952280455     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.12.010     Document Type: Article

References (30)

1. J.M. Bhardwa, T. Powles, D. Berney, S. Baithun, V.H. Nargund, and R.T.D. Oliver Assessing the size and stage of testicular germ cell tumours: 1984-2003 BJU Int 96 2005 819 821 (Pubitemid 41391389)
2. G. Read, S.P. Stenning, and M.C. Cullen Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party J Clin Oncol 10 1992 1762 1768 (Pubitemid 23059954)
3. R.S. Foster, and J.P. Donohue Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma J Urol 163 2000 1788 1792 (Pubitemid 30366737)
4. M.H. Cullen, S.P. Stenning, and M.C. Parkinson Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report J Clin Oncol 14 1996 1106 1113 (Pubitemid 26105516)
5. A.M. Al Ghamdi, and M.A. Jewett Stage I nonseminomatous germ cell tumors: the case for management by risk stratification Can J Urol 12 Suppl 1 2005 62 65 discussion 103-4
6. R.J. Groll, P. Warde, and M.A.S. Jewett A comprehensive systematic review of testicular germ cell tumor surveillance Crit Rev Oncol Hematol 64 2007 182 197 (Pubitemid 350026782)
7. C. Kollmannsberger, C. Moore, and K.N. Chi Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy Ann Oncol 21 2010 1296 1301
8. P. Maroto, X. Garcia del Muro, and J. Aparicio Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours Ann Oncol 16 2005 1915 1920 (Pubitemid 41724280)
9. R.T. Divrik, B. Akdogan, Ozen Haluk, and F. Zorlu Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors - is shift to risk adapted policy justified? J Urol 176 2006 1424 1430 (Pubitemid 44307195)
10. D. Ondrus, J. Matoska, V. Belan, J. Kausitz, F. Goncalves, and M. Hornak Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment Eur Urol 33 1998 562 566 (Pubitemid 28284800)
11. T. Tandstad, O. Dahl, and G. Cohn-Cedermark Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: The SWENOTECA management program J Clin Oncol 27 2009 2122 2128
12. P. Albers, R. Siener, and S. Kliesch Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial J Clin Oncol 21 2003 1505 1512 (Pubitemid 46594103)
13. S. Sharir, M.A.S. Jewett, and J.F. Sturgeon Progression detection of stage I nonseminomatous testis cancer on surveillance: Implications for the follow up protocol J Urol 161 1999 472 476
14. D. Vugrin, H.W. Herr, W.F. Whitmore Jr., P.C. Sogani, and R.B. Golbey VAB-6 combination chemotherapy in disseminated cancer of the testis Ann Intern Med 95 1981 59 61 (Pubitemid 11079022)
15. S.D. Williams, R. Birch, L.H. Einhorn, L. Irwin, F.A. Greco, and P.J. Loehrer Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide N Engl J Med 316 1987 1435 1440 (Pubitemid 17079090)
16. A. Heidnreich, I.A. Sesterhenn, F.K. Mostofi, and J.W. Moul Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis Cancer 83 1998 1002 1011 (Pubitemid 28401935)
17. R.J. Amato, J.Y. Ro, A.G. Ayala, and D.A. Swanson Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis Urology 63 2004 144 149
18. U.E. Studer, F.C. Burkhard, and R.W. Sonntag Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage I nonseminomatous germ cell tumor J Urol 163 2000 1785 1787 (Pubitemid 30366736)
19. G.J. Rustin, G.M. Mead, and S.P. Stenning Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - the National Cancer Research Institute Testis Cancer Clinical Studies Group J Clin Oncol 25 2007 1310 1315 (Pubitemid 46706876)
20. D.J. Brenner, and C.D. Elliston Estimated radiation risks potentially associated with full-body CT screening Radiology 232 2004 735 738 (Pubitemid 39100257)
21. A. Berrington de Gonzalez, and S. Darby Risk of cancer from diagnostic x-rays: estimates for the UK and 14 other countries Lancet 363 2004 345 351 (Pubitemid 38169539)
22. R. Segal Surveillance programs for stage I nonseminomatous germ cell tumors of the testis Urol Oncol 24 2006 68 74 (Pubitemid 43097360)
23. P. Albers, R. Siener, and S. Krege Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I non-seminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group J Clin Oncol 26 2008 2966 2972
24. J.J. Rassweiler, W. Scheitlin, A. Heidenreich, M.P. Laguna, and G. Janetschek Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective Eur Urol 54 2008 1004 1019
25. C. Nguyen, A. Fu, and T. Gilligan Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis J Clin Oncol 28 2010 119 125
26. M.H. Cullen, L.J. Billingham, J. Cook, and C.M. Woodroffe Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists Br J Cancer 74 1996 1487 1491 (Pubitemid 26370745)
27. L. Wood, C. Kollmannsberger, and M. Jewett Canadian consensus guidelines for the management of testicular germ cell cancer Can Urol Assoc J 4 2010 E19 38
28. H.-J. Schmoll, K. Jordan, and R. Huddart Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl 5 2010 v147 v154
29. Albers P, Albrecht W, Algaba F, et al. Guidelines on testicular cancer. European Association of Urology Web site. http://www.uroweb.org/guidelines/ online-guidelines/.
30. S. Krege, J. Beyer, and R. Souchon European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European germ cell cancer consensus group (EGCCCG): Part I Eur Urol 53 2008 478 496